Pancreas Screening in High Risk Individuals
NCT07012018 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-06-10
Summary
Pancreas cancer is the 11th most common cancer in Canada but the 4th most common cause of cancer death because by the time pancreas cancer is detected, it is almost always too advanced for surgery. There are known factors that put individuals at higher risk for pancreas cancer. These include: certain genetic mutations, a family history of pancreas cancer, pancreas cysts and a new diagnosis of diabetes mellitus. Individuals with these risk factors are recommended to undergo pancreas screening with blood tests and yearly imaging tests of the pancreas. Our study will enroll patients with these risk factors and ensure they are managed as per guidelines. Prospectively collected data will include: patient clinicodemographic details, lifestyle factors, screening test results, clinical outcomes and patient reported outcome measures.
Conditions
- Pancreas Cancer Screening
Sponsors & Collaborators
-
University of British Columbia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2035-12-31
- Completion
- 2035-12-31
More Related Trials
-
Quebec Pancreas Cancer Study
NCT04104230 ·Status: RECRUITING
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN
-
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT06151223 ·Status: RECRUITING
-
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
NCT06122896 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
NCT03250078 ·Status: RECRUITING
-
Pancreatic Cancer Early Detection Program
NCT02206360 ·Status: ACTIVE_NOT_RECRUITING
-
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
NCT03060720 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
NCT03693378 ·Status: COMPLETED
-
Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.
NCT02072616 ·Status: TERMINATED ·Phase: NA
-
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
NCT02478892 ·Status: RECRUITING
-
Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)
NCT00714701 ·Status: COMPLETED
-
Pancreatic Cancer Early Detection Consortium
NCT04970056 ·Status: RECRUITING
-
Pancreatic Cancer Screening in a Population at High Risk
NCT06330441 ·Status: RECRUITING ·Phase: NA
-
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
NCT02869802 ·Status: RECRUITING
-
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
NCT06271291 ·Status: RECRUITING
-
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
NCT04473794 ·Status: RECRUITING
-
Pancreatic Cancer Collaborative Registry
NCT00661882 ·Status: COMPLETED
-
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
NCT07030348 ·Status: RECRUITING
-
Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
NCT00559598 ·Status: COMPLETED
-
Identification of Biomarkers for Early Detection of Pancreatic Cancer
NCT00897494 ·Status: COMPLETED
-
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147 ·Status: RECRUITING
-
Early Screening of Pancreatic Lesions : Development of New Imaging Tools
NCT04007640 ·Status: UNKNOWN ·Phase: NA
-
Cancer of the Pancreas Screening Study (CAPS 3)
NCT00438906 ·Status: COMPLETED
-
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
NCT01411072 ·Status: UNKNOWN ·Phase: NA
-
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice
NCT02277834 ·Status: COMPLETED